Treatment of childhood acute nonlymphocytic leukemia with high-dose cytosine arabinoside, 6-thioguanine, and doxorubicin without maintenance therapy: pilot study ANLL-80 of the Dutch Childhood Leukemia Study Group (DCLSG).

MLA

van der Does-van den Berg, A., et al. “Treatment of Childhood Acute Nonlymphocytic Leukemia with High-Dose Cytosine Arabinoside, 6-Thioguanine, and Doxorubicin without Maintenance Therapy: Pilot Study ANLL-80 of the Dutch Childhood Leukemia Study Group (DCLSG).” Pediatric Hematology and Oncology, vol. 5, no. 2, 1988, pp. 93–102. EBSCOhost, https://doi.org/10.3109/08880018809031259.

APA

van der Does-van den Berg, A., Hhlen, K., Colly, L. P., & Vossen, J. M. (1988). Treatment of childhood acute nonlymphocytic leukemia with high-dose cytosine arabinoside, 6-thioguanine, and doxorubicin without maintenance therapy: pilot study ANLL-80 of the Dutch Childhood Leukemia Study Group (DCLSG). Pediatric Hematology and Oncology, 5(2), 93–102. https://doi.org/10.3109/08880018809031259

Chicago

van der Does-van den Berg, A, K Hhlen, L P Colly, and J M Vossen. 1988. “Treatment of Childhood Acute Nonlymphocytic Leukemia with High-Dose Cytosine Arabinoside, 6-Thioguanine, and Doxorubicin without Maintenance Therapy: Pilot Study ANLL-80 of the Dutch Childhood Leukemia Study Group (DCLSG).” Pediatric Hematology and Oncology 5 (2): 93–102. doi:10.3109/08880018809031259.